Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levonorgestrel Plus Meloxicam for Delaying Ovulation in Obese Women
NCT06306131Phase 2Completed
- Sponsor
- InnovaGyn, Inc.
- Start
- Dec 2023
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of avatrombopag, meloxicam in contraception, sponsored by InnovaGyn, Inc.. Started Dec 2023; status: completed.
02
Drugs
avatrombopagmeloxicam
03
Conditions
contraception
Beyond the preview
Go deeper on NCT06306131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06306131.